AJOONI3.49

Ajooni Biotech Limited

· Unclassified
AnnualQuarterly₹ CrorePeersTOUCHWOODRKECRAJMETBANKAAAKASHGANGAFORGEGLOBEAGROPHOSMcap ₹60.1 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations80.1114.7182.4214.6
Other Income2.22.12.42.0
Total Income82.3116.8184.8216.6
Expenses
+ Cost of Materials Consumed69.997.2148.1177.0
+ Changes in Inventories0.5-0.1-0.1-0.5
+ Employee Benefit Expense1.82.84.65.0
+ Finance Costs0.60.30.71.1
+ Depreciation & Amortisation0.91.12.22.8
+ Other Expenses5.711.223.625.9
Total Expenses79.3112.4179.1211.3
EBITDA2.23.76.37.2
EBIT1.42.64.04.5
Profit
PBT before Exceptional Items3.04.35.75.4
Pretax Income3.04.35.75.4
+ Current Tax0.91.01.51.5
+ Deferred Tax-0.0-0.1-0.1-0.1
Tax Expense0.81.01.41.4
Net Income2.23.44.34.0
+ Net Income — Continuing Ops2.23.44.34.0
+ Other Comprehensive Income-1.0-0.3-1.2-1.2
Total Comprehensive Income1.13.13.12.7
Per Share
Basic EPS0.250.200.250.24
Diluted EPS0.250.200.250.24
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.3-1.2
+ Items NOT to be Reclassified to P&L-0.3-1.2
Per Share — as-filed variants
Basic EPS — Continuing Operations0.250.200.250.24
Diluted EPS — Continuing Operations0.250.200.250.24
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit9.817.734.538.1
Gross Margin %12.1915.4018.8917.76
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)3.04.35.75.4
Net Income Adj (tax-effected)2.23.44.34.0
EPS Adj0.250.200.250.24
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital17.534.434.434.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.